CARLA LATOURETTE: Open Payments
NPI 1982643672 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 33 payments from 12 companies in 2025. Trend: 2023 $1,328 · 2024 $704 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $163 |
| Amgen Inc. | 9 | $141 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| PFIZER INC. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Davol Inc. | 1 | $21 |
Products named: LEQVIO, REPATHA, NEXLETOL, ONPATTRO, ELIQUIS, VYNDAQEL, CAMZYOS, FUROSCIX.
Industry payments across FL — which companies pay providers there.
